Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Urology|October 24, 2002
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancerCharles J Rosser, Deborah A Kuban, Lawrence B Levy, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 6, 2006
Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancerScott B Cantor, Lawrence B Levy, Marylou Cárdenas-Turanzas, et al.
Clinical Lung Cancer|December 3, 2014
Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapyHongmei Wang, Zhongxing Liao, Yan Zhuang, et al.
Translational Oncology|February 12, 2017
The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive RadiotherapyJu Yang, Ting Xu, Daniel R Gomez, et al.
Urology|June 9, 2004
Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failureAshish M Kamat, Charles J Rosser, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2014
Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancerChad Tang, Daniel R Gomez, Hongmei Wang, et al.
BJU International|October 19, 2016
Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinomaJay P Reddy, Curtis A Pettaway, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|February 4, 2012
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapyJ Taylor Whaley, Lawrence B Levy, David A Swanson, et al.
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
Brachytherapy|March 8, 2013
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trialSteven P Register, Rajat J Kudchadker, Lawrence B Levy, et al.
Pageof 6